HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

Guang Yang; Sara J. Buhrlage; Li Tan; Xia Liu; Jie Chen; Lian Xu; Nicholas Tsakmaklis; Jiaji G. Chen; Christopher J. Patterson; Jennifer R. Brown; Jorge J. Castillo; Wei Zhang; Xiaofeng Zhang; Shuai Liu; Philip Cohen; Zachary R. Hunter; Nathanael Gray; Steven P. Treon

doi:10.1182/blood-2016-01-695098

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

Guang Yang
, Sara J. Buhrlage
, Li Tan
, Xia Liu
, Jie Chen
, Lian Xu
, Nicholas Tsakmaklis
, Jiaji G. Chen
, Christopher J. Patterson
, Jennifer R. Brown
, Jorge J. Castillo
, Wei Zhang
, Xiaofeng Zhang
, Shuai Liu
, Philip Cohen
, Zachary R. Hunter
, Nathanael Gray
, Steven P. Treon

Chemistry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	3237-3252
Number of pages	16
Journal	Blood
Volume	127
Issue number	25
DOIs	https://doi.org/10.1182/blood-2016-01-695098
State	Published - Jun 23 2016

ASJC Scopus Subject Areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2016-01-695098

Cite this

Yang, G., Buhrlage, S. J., Tan, L., Liu, X., Chen, J., Xu, L., Tsakmaklis, N., Chen, J. G., Patterson, C. J., Brown, J. R., Castillo, J. J., Zhang, W., Zhang, X., Liu, S., Cohen, P., Hunter, Z. R., Gray, N., & Treon, S. P. (2016). HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood, 127(25), 3237-3252. https://doi.org/10.1182/blood-2016-01-695098

Yang, G, Buhrlage, SJ, Tan, L, Liu, X, Chen, J, Xu, L, Tsakmaklis, N, Chen, JG, Patterson, CJ, Brown, JR, Castillo, JJ, Zhang, W, Zhang, X, Liu, S, Cohen, P, Hunter, ZR, Gray, N & Treon, SP 2016, 'HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib', Blood, vol. 127, no. 25, pp. 3237-3252. https://doi.org/10.1182/blood-2016-01-695098

@article{16797f8192ab42428e0665626d43bdce,

title = "HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib",

author = "Guang Yang and Buhrlage, \{Sara J.\} and Li Tan and Xia Liu and Jie Chen and Lian Xu and Nicholas Tsakmaklis and Chen, \{Jiaji G.\} and Patterson, \{Christopher J.\} and Brown, \{Jennifer R.\} and Castillo, \{Jorge J.\} and Wei Zhang and Xiaofeng Zhang and Shuai Liu and Philip Cohen and Hunter, \{Zachary R.\} and Nathanael Gray and Treon, \{Steven P.\}",

note = "Publisher Copyright: {\textcopyright} 2016 by The American Society of Hematology.",

year = "2016",

month = jun,

day = "23",

doi = "10.1182/blood-2016-01-695098",

language = "English",

volume = "127",

pages = "3237--3252",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "25",

}

TY - JOUR

T1 - HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

AU - Yang, Guang

AU - Buhrlage, Sara J.

AU - Tan, Li

AU - Liu, Xia

AU - Chen, Jie

AU - Xu, Lian

AU - Tsakmaklis, Nicholas

AU - Chen, Jiaji G.

AU - Patterson, Christopher J.

AU - Brown, Jennifer R.

AU - Castillo, Jorge J.

AU - Zhang, Wei

AU - Zhang, Xiaofeng

AU - Liu, Shuai

AU - Cohen, Philip

AU - Hunter, Zachary R.

AU - Gray, Nathanael

AU - Treon, Steven P.

PY - 2016/6/23

Y1 - 2016/6/23

UR - https://www.scopus.com/pages/publications/84994683978

UR - https://www.scopus.com/pages/publications/84994683978#tab=citedBy

U2 - 10.1182/blood-2016-01-695098

DO - 10.1182/blood-2016-01-695098

M3 - Article

C2 - 27143257

AN - SCOPUS:84994683978

SN - 0006-4971

VL - 127

SP - 3237

EP - 3252

JO - Blood

JF - Blood

IS - 25

ER -

HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this